METHODS	This 1-year , multinational , randomised , double-blind substudy evaluated the efficacy and safety of ~ 10 mg/kg and ~ 5 mg/kg abatacept in patients with early RA with poor prognosis who had reached DAS28 ( ESR ) < 2.6 at year 2 of the AGREE study .\